IRISQUINONE
IRISQUINONE Basic information
- Product Name:
- IRISQUINONE
- Synonyms:
-
- 2-(10-heptadecenyl)-6-methoxy-5-cyclohexadiene- (z)-4-dione
- 2-(10-heptadecenyl)-6-methoxy-5-cyclohexadiene-(z)-4-dione
- 6-methoxy-2-delta(sup 10')-cis-heptadecenyl-1,4-benzoquinone
- pallasone
- 2-[(Z)-10-Heptadecenyl]-6-methoxy-2,5-cyclohexadiene-1,4-dione
- Irisquinone A
- IRISQUINONE
- 2,5-Cyclohexadiene-1,4-dione, 2-(10Z)-10-heptadecen-1-yl-6-methoxy-
- CAS:
- 56495-82-0
- MF:
- C24H38O3
- MW:
- 374.56
- Mol File:
- 56495-82-0.mol
IRISQUINONE Chemical Properties
- Melting point:
- 40-43 °C
- Boiling point:
- 483.4±34.0 °C(Predicted)
- Density
- 0.97±0.1 g/cm3(Predicted)
- LogP
- 8.850 (est)
IRISQUINONE Usage And Synthesis
Uses
Irisquinone, a natural product, is an anticancer agent. Irisquinone is also a radiation sensitizer for cancer. Irisquinone reduces GSH level and inhibits the repair of DNA singular strand breaks[1][2][3].
in vivo
Irisquinone (12.5 mg/kg, perfused daily) makes the rabbit VX2 lung transplant tumor wall thinner and the necrotic area larger in the irisquinone + radiotherapy group[1].
| Animal Model: | Rabbit bearing VX2 lung transplant tumor[1] |
| Dosage: | 12.5 mg/kg |
| Administration: | Perfused daily, starting from 3 days before irradiation to the end of irradiation. |
| Result: | Displayed no significant difference of tumor growth between the radio therapy and Irisquinone + radiotherapy groups. Showed thinner tumor wall and the larger necrotic area in the Irisquinone + radiotherapy group. |
References
[1] Xu H, et al. Dynamic observation of the radiosensitive effect of irisquinone on rabbit VX2 lung transplant tumors by using fluorine-18-deoxyglucose positron emission tomography/computed tomography. Nucl Med Commun. 2013 Mar;34(3):220-8. DOI:10.1097/MNM.0b013e32835d3730
[2] Wang H, et al. Radiosensitizing effect of irisquinone on glioma through the downregulation of HIF-1α evaluated by 18F-FDG and 18F-FMISO PET/CT. Nucl Med Commun. 2016 Jul;37(7):705-14. DOI:10.1097/MNM.0000000000000498
[3] Liang, l., et al. The effect of Irisquinone on the glutathione system and MRP expression of cisplatin-resistant human lung adenocarcinoma cell line (A DDP549). Chin J Cancer Res 13, 171–175 (2001).
IRISQUINONESupplier
- Tel
- 021-38218169 13341702378
- winherb@126.com
- Tel
- 0512-87182056 18013166090
- lingling.qi@yacoo.com.cn
- Tel
- sales@njromanme.com
- Tel
- 028-028-85370565-229-229 18080489829
- 18080489829@163.com
- Tel
- info@bocsci.com